Life Sciences Review

Lina Parra Cartagena, Associate Director of Finance, Vertex Pharmaceuticals Contributed an article "The Impact of AI on FP&A in the Life Sciences Sector" “AI's predictive analytics can revolutionize financial forecasting in the Life Sciences sector, improving accuracy, resource allocation, and risk management while driving broader medication access and lowering healthcare costs.” says Lina Parra Cartagena The article will also be featured in the forthcoming special print edition of Life Science Financial Services 2024. Read More : https://lnkd.in/g7W_neiq #FinancialPlanning #BiotechFinance #DigitalTransformation #FinanceAutomation #HealthcareFinance

Matt Pugh, PhD, SVP of Medical and Scientific Services at Ashfield MedComms, an Inizio Medical Company Contributed an article " The Evolution of Medical Communications: Enabling an Increased Strategic Role for Medical Affairs Functions" "Arguably, the hottest topic currently within healthcare communications is the growing influence of AI, which will likely have a far-reaching impact across our industry over the coming years" says Matt Pugh The article will also be featured in the forthcoming special print edition of  CRO 2024. Read More : https://lnkd.in/g24i4aii #MedicalCommunications #PharmaInnovation #HealthcareCommunication #StrategicHealthcare #PatientEngagement #HealthTechnology #DrugDevelopment

Transcriptome Sciences Inc. has been recognized as one of the Top Biotech Canada Company by Life Sciences Review. TSI is a global leader in transplant diagnostics, utilizing advanced molecular technology to provide precise, genome-wide assessments of biopsies. It collaborates with international partners to improve patient outcomes and support clinical trials, revolutionizing transplant medicine through innovative solutions. “We have developed a system that overcomes the limitations of traditional histology, which is plagued by subjectivity, reproducibility challenges, and the inability to capture specific molecular details,” says Philip Halloran, CEO. The article will also be featured in the forthcoming special print edition of Biotech 2024. Read More : https://lnkd.in/gEvFjPWa #TransplantDiagnostics #MolecularTechnology #PatientOutcomes #TransplantMedicine #HealthcareInnovation #PrecisionMedicine

Ivan A Salazar, Plant Production Manager, Organigram Inc Contributed an article "The Therapeutic Potential of Cannabis: A Global Perspective on Clinical Findings" "Clinical findings show that cannabis can help manage chemotherapy-induced nausea and vomiting, improve appetite, and mitigate pain in cancer patients" says Ivan A Salazar The article will also be featured in the forthcoming special print edition of Clinical Trial Management 2024. Read More : https://lnkd.in/givqWXbf #CannabisTherapy #MedicalCannabis #CannabisResearch #MentalHealth

Ivan Salazar, Plant Production Manager at Organigram Contributed an article "Innovations in the Cannabis and Hallucinogenic Industries." The article will also be featured in the forthcoming special print edition of Biomanufacturing 2024. Read More : https://lnkd.in/gxnDdaz7 #CannabisInnovation #PsychedelicScience #HallucinogenResearch #PsychedelicInnovation #PsychedelicTherapy #PsychedelicIndustry

AgencyIQ has been recognized as the Life Sciences Regulation Insights Company of the Year by Life Sciences Review. A division of POLITICO, AgencyIQ was born from a pressing need expressed by subscribers over seven years ago. Today, the business operates as a strategic partner and extension of subscribers’ teams by offering regulatory professionals with reliable access to analysis and insights, real-time data, and non-partisan journalism. “Our vision is to enable businesses to deeply understand, seamlessly track, and effectively engage with regulators to accelerate action and improve outcomes,” says Alexander Gaffney, MS, RAC, Executive Director of Regulatory Policy and Intelligence at AgencyIQ. “POLITICO’s reputation as one of the world’s most trusted sources for high-quality information on politics and policy, combined with its foothold in Brussels, puts AgencyIQ in a strong position to expand geographically, especially in Europe” says Joseph Kenol, AgencyIQ’s Vice President & General Manager. The article will also be featured in the forthcoming special print edition of Life Sciences Regulation Insights 2024. Read More : https://lnkd.in/gW2rumNx #IntelligenceDivision #RegulatoryIntelligence #IndustryRegulation #StrategicPartnerships #GovernmentAffairs

BIOVIIIx has been recognized as the Hemophilia Company of the Year In Europe by Life Sciences Review. BIOVIIIx is a family-run biotech firm that excels in haemophilia and rare diseases. Focusing on scientific research and global partnerships, it rapidly advances treatments and develops innovative solutions. The company invests in employee training, business modernisation and R&D, aiming for international growth through new business units and expanded therapeutic approaches "BIOVIIIx is grounded in ethical and human-centric values. Its decision-making process focuses on projects that directly benefit patients, often foregoing immediate financial gains. This patient-centric approach leads the company to go above and beyond standard practices." says Davide Rosiello, CEO The article will also be featured in the forthcoming special print edition of Hemophilia 2024. Read More : https://lnkd.in/gRB9nJiH #BiotechInnovation #ScientificResearch #HealthcareInnovation #InnovativeTherapies #PharmaResearch #EmployeeTraining

Ivan Salazar, Plant Production Manager, Organigram Contributed an article "The Impact of COVID-19 on Cannabis Consumption: Trends and Future Projections" "As consumers embrace the myriad benefits of cannabis, the future of consumption holds promise for a thriving industry that is increasingly becoming a fundamental part of modern life." says Ivan Salazar The article will also be featured in the forthcoming special print edition of Peptides 2024. Read More : https://lnkd.in/g_sgD3EU #CannabisConsumption #PandemicTrends #CannabisIndustry #PostPandemic

Dae Wook Lee, Medicine, MBA, Medical Director, Pharmaceuticals Korea, Clinical Development and Medical Affairs, Republic of Korea, at Novartis Contributed an article "Implication of Generative AI in Biotechnology" “As the field continues to evolve, the collaboration between generative AI and biotechnology will undoubtedly pave the way for a future where scientific breakthroughs and medical advancements are more accessible and impactful than ever before.” says Dae Wook Lee, The article will also be featured in the forthcoming special print edition of Life Sciences AI 2024. Read More : https://lnkd.in/gji-8Vrj #Biotechnology #BiotechInnovation #MachineLearning #DrugDiscovery #GeneticEngineering #PrecisionMedicine

Helen Yeardley, Senior Vice President, Clinical Operations, ICON, [NASDAQ: ICLR] Contributed an article "The Significant Increase in Demand for Clinical Research Associates (CRAs)" "At ICON, we are looking at how to address this current challenge from number of practical perspectives" says Helen Yeardley The article will also be featured in the forthcoming special print edition of  LSR Public Companies 2024. Read More : https://lnkd.in/gqXiMENU #ClinicalResearch #HealthcareInnovation #HealthTech #BiotechCareers